Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Biopharmaceutics II > New Material > Flashcards

New Material Flashcards

1
Q

The drug fraction REMAINING from initial concertation at any time after the dose is represented by the expression

A

e^-kt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is each subsequent dose additively influences the total plasma concentration

A

The principle of superposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the PK profile is a series of peaks (Cmax) and troughs (Cmin)

A

Fluctuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Accumulation depends on the dosing interval (t) relative to the drug’s

A

Half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

At steady-state, the peaks and troughs are the same for

A

Successive doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The time difference between Cmax amd Cmin =

A

Tau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A patient is to be given gentamicin IV to achieve steady-state peaks and troughs of 8 and 0.5 mg/L. The patient is estimated to have the following PK parameters: Vd =17.5 L and t1/2 = 2 h.
If multiple doses are to be given, determine a suitable dose and dosing interval for this patient.

A

131 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the TYPICAL IV DOSING
INTERVALS

A

4,6,8,12,24 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A new drug has a very narrow therapeutic range (12–25 mg/L). The goal is to design a dosing regimen that will result in a steady-state peak and trough of 20 and 14 mg/L, respectively. The drug’s elimination rate constant has a population average value of 0.043 h−1. What dosing interval is needed to provide the desired steady-state peaks and troughs?

A

8h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A patient is to be given gentamicin IV to achieve steady-state peaks and troughs of 8 and 0.5 mg/L. The patient is estimated to have the following PK parameters: Vd =17.5 L and t1/2 = 2 h.
If multiple doses are to be given, determine a suitable dose and dosing interval for this patient.

A

8h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A patient is receiving 1000 mg of sulfamethoxazole IV every 12 hours. At steady state, the max and min plasma concentrations were 81.5 and 40 mg/L, respectively. What is the volume of distribution of sulfamethoxazole in this patient?

A

24 L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the PK profile features of multiple oral doses?

A
  1. Fluctuation
  2. Delayed Cmax due to absorption
  3. Accumulation
  4. about 5 half-lives to steady state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a parameter used to quantify the ultimate amount of drug accumulation in the body at steady-state (Ra)

A

Accumulation factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What compares the steady state plasma concertation to the equivalent concentration after the first dose:

A

Accumulation factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If administered every half-life, there will be _____ times more drug in the body at SS then after a single dose

A

1.44

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The average Cp ss is ______ the arithmetic mean of the max and min Cp at steady state

A

NOT

17
Q

At steady state, plasma drug concentrations fluctuate around the average ____ during multiple drug administration

A

Cp

18
Q

Consider the following dosing regimens of the same drug (F = 1):

100 mg Q 4h
200 mg Q 8h
300 mg Q 12h

Would all of these regimens provide the same dosing rate (FD/t)?

A

yes all are 25

19
Q

Multiple Oral Drug Administration: ModelAssumptions

Compartment open model?

A

One-compartment open model

20
Q

Multiple Oral Drug Administration: ModelAssumptions

Rate of drug absorption?

A

Is rapid (no lag time) and follows first-order kinetics

21
Q

Multiple Oral Drug Administration: ModelAssumptions

When each doses is administered?

A

Each dose is administered after the majority of the previous dose is absorbed

22
Q

Multiple Oral Drug Administration: ModelAssumptions

What factor is considered?

A

Bioavailability factor (F)

23
Q

Multiple Oral Drug Administration: ModelAssumptions

Predicted peak and trough concentrations?

A

The predicted peak and trough concentrations are NOT accurate

24
Q

Multiple Oral Drug Administration: ModelAssumptions

Elimination order?

A

Elimination is first-order process

25
Q

What are the 3 impacts of the Drug Absorption Rate on the Predicted Plasma Concentrations

A
  1. A faster absorption rate yields more accurate prediction
  2. A slower absorption rate results in an overestimation of Cmax
  3. Absorption rate has a negligible impact on Cmin
26
Q

Given parameters: Vd = 80 L, CL = 20 L/h, t1/2 = 4 h, and F = 0.85,
Cmax ss= 50 ug/L, Cmin ss = 25 ug/L.

Dose - ?
Dosing interval - ?
Cp ss av - ?

A

Dose: 2353 micrograms
Dosing interval: 4 h
Cp ss av: 0.036 mg/L

27
Q

What is the key mechanism of nonlinear PK behavior?

A

The concentration-dependent saturation of a carrier or enzyme involved in the drug ADME processes.

28
Q

Nonlinear PK implies a

A

Dose- or time-dependency of PK processes

29
Q

For nonlinear PK’s what 3 things depend on the dose of the drug?

A

CL
Half-life
F

30
Q

For nonlinear elimination CL and t1/2 are concentration

A

Dependent

31
Q

Doubling the dose of the drugs that follow nonlinear PK may more than double the

A

Cp

32
Q

The most clinically important type of nonlinear pharmacokinetics is _________ metabolism

A

satuarble

33
Q

All active drug transport processes are capacity limited (saturable) and exhibit what kinetics?

A

Michaelis-Menten kinetics

34
Q

Km =

A

the Michaelis-Menten
constant (the concentration that produces 50% of VMAX)

35
Q

Michaelis-Menten Kinetics use what 3 orders?

A
  1. 1st order
  2. Mixed order
  3. Zero order
36
Q

At high concentrations
(C&raquo_space; Km), Vmax =

A

Amount of the drug removed per unit time

37
Q

A patient has been using phenytoin 100 mg three times daily. The phenytoin level was drawn and found to be 8.8. ug/mL (reference range 10-20 ug/mL). The prescriber doubled the dose to 200 mg three times daily. The patient started to slur her words, felt fatigued and returned to the clinic. The level was repeated and found to be 23.7 ug/mL. Which of the following statement is accurate regarding the most likely reason for the change in phenytoin level?

a. Phenytoin half-life is reduced at higher doses.
b. Phenytoin volume of distribution increases at higher doses.
c. Phenytoin bioavailability can decrease at higher doses.
d. Phenytoin metabolism can become saturated at higher doses.

A

d

38
Q

Drug T has a VMAX of 600 mg/d and a KM of 12 mg/L. What is the clearance for Drug T when C = 100 mg/L

A

5.4 L/day

39
Q

Known parameters: Cpss = 15 mg/L Vmax = 400 mg/day
Km = 4mg/L, S = 0.92, F=1
Dosing Rate - ?

A

343 mg/day

Biopharmaceutics II (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions